Telencik-MT Tablet ER
Marketer
Alencik Pharmaceuticals Private Limited
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Telencik-MT Tablet ER
CardioTen ER tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking CardioTen ER with food daily, at the same time, as prescribed. Continued use is crucial, even feeling well, as hypertension is often asymptomatic; premature discontinuation can worsen the condition. Lifestyle changes, including exercise, weight management, and a healthy diet, complement treatment. Follow your physician's guidance carefully. Potential side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), shortness of breath, nausea, vomiting, abdominal pain, fatigue, and elevated potassium levels. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any kidney or liver issues, and pregnant or breastfeeding women should seek medical advice before use. Always disclose all medications, particularly those for hypertension or heart conditions.
Primary Ingredients of Telencik-MT Tablet ER
No text was provided to rewrite.
Uses of Telencik-MT Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Telencik-MT Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Telencik-MT Extended-Release Tablets. Ingest the tablets whole; do not crush, chew, or break them. Consume this medication with food.
Common Side effects of Telencik-MT Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telencik-MT Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Telencik-MT Extended-Release Tablets with a meal.
How Telencik-MT Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in the extended-release Telencik-MT Tablet, work together to reduce blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Telencik-MT Extended-Release Tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Telencik-MT Extended-Release Tablets is contraindicated in pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telencek-MT tablets appear to pose minimal breastfeeding risk. Available human data indicate negligible infant hazard.
DrivingUNSAFE
Extended-release Telencik-MT tablets can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these side effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Telencik-MT tablets are considered safe for use in individuals with renal impairment. No modification of the Telencik-MT tablet extended-release dosage is advised.
LiverCAUTION
Patients with liver impairment should use Telencik-MT Extended-Release tablets cautiously. Dosage modification of Telencik-MT Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Telencik-MT Tablet ER :
Should you forget a Telencik-MT Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telencik-MT Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
3,018 People bought this recently